Supplier profile
Merck Serono
Every public-sector award we hold for this supplier, across Denmark, Spain, France, the UK, Italy and UK, from 1 Aug 2008 to 6 Jul 2026.
Awards won
331
all time
Attributed value
£12.0m + €73.4m
224 shared, unvalued
Buyers
154
public bodies
Active
2008–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 9 | £5.9m |
| The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’) | 5 | £5.9m |
| DEPARTMENT OF HEALTH AND SOCIAL CARE | 1 | £101k |
| Department of Health and Social Care | 1 | £101k |
| NHS England | 54 | not attributable |
| The NHS Commissioning Board (operating under the name of NHS England) | 12 | not attributable |
| AP-HM | 8 | €55.2m |
| CHG de Saint-Brieuc | 8 | €627k |
| Centre hospitalier de Béziers | 6 | not attributable |
| Centre hospitalier de Nevers | 6 | €11k |
What they win
Awards
Showing 1–25 of 331 awards we hold
- NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 ↗NHS Englandshared awardawarded 6 Jul 2026
- NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 ↗NHS Englandawarded 15 Jun 2026
- NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 ↗NHS Englandshared awardawarded 15 Jun 2026
- NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 ↗NHS Englandshared awardawarded 25 Jun 2025
- NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 ↗NHS Englandshared awardawarded 25 Jun 2025
- NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National ↗NHS Englandshared awardawarded 25 Jun 2025
- Medicinal Products and Pharma Funded Homecare [5749446] ↗Regional Business Services Organisation Procurement and Logistics Serviceshared awardawarded 12 Jun 2025
- NP47825 Multiple Sclerosis Medicines ↗The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)shared awardawarded 15 Apr 2025
- Italy – Various medicinal products – ARIA_2024_008.10 - Procedura aperta multilotto, ai sensi dell’art. 71 del D.Lgs 36/2023 e ss.mm.ii., per la fornitura di farmaci e servizi connessi ↗ARIA - Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.shared awardawarded 26 Mar 2025
- NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 ↗NHS Englandshared awardawarded 24 Mar 2025
- NHS Framework Agreement for Branded Medicines - Proprietary Category Tender ↗NHS Englandshared awardawarded 24 Mar 2025
- NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 ↗NHS Englandshared awardawarded 24 Mar 2025
- NP49024 Growth Hormone ↗The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)shared awardawarded 7 Jan 2025
- Italy – Various medicinal products – ARIA_2024_008.5 - Procedura aperta multilotto, ai sensi dell’art. 71 del D.Lgs 36/2023 e ss.mm.ii., per la fornitura di farmaci e servizi connessi ↗Azienda Regionale Centrale Acquistishared awardawarded 27 Aug 2024
- France – Antineoplastic and immunomodulating agents – AO MEDICAMENTS ANTINEOPLASIQUES ET IMMUNOMODULATEURS (Classe ATC L) ↗CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMORshared awardawarded 28 May 2024
- Italy – Other therapeutic products – ARIA_2023_011.15 Procedura aperta multilotto ai sensi dell’art. 71 del D.Lgs. n. 36/2023 per la conclusione di Accordi Quadro, che saranno eseguiti ex art. 59, comma 3 e 4, lettera a), del D.Lgs. n. 36/2023 per la fornitura di farmaci biologici/biosimilari e servizi connessi ↗ARIA Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.shared awardawarded 24 May 2024
- France – Antineoplastic and immunomodulating agents – Fourniture de médicaments cytotoxiques pour le GHT 44 ↗CHU NANTESshared awardawarded 8 May 2024
- NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 ↗NHS Englandshared awardawarded 8 Apr 2024
- NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 ↗NHS Englandshared awardawarded 8 Apr 2024
- NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 ↗NHS Englandshared awardawarded 5 Apr 2024
- NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 ↗NHS Englandshared awardawarded 26 Jan 2024
- NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 ↗NHS Englandshared awardawarded 26 Jan 2024
- NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 ↗NHS Englandshared awardawarded 26 Jan 2024
- Italy-Genoa: Various medicinal products ↗Regione Liguria - settore SUAR - sede legale: Via Fieschi 15 - 16121 Genovashared awardawarded 20 Oct 2023
- Italy-Perugia: Pharmaceutical products ↗PUNTOZERO SCARLshared awardawarded 25 Aug 2023
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.